Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-23-015351

Director acquired 2,852 shares (code L)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Krogulski Kenneth Director 2023-11-01 Other acquisition 10b5-1 +280 $1.85 $518 225,287 D
Krogulski Kenneth Director 2023-11-02 Other acquisition 10b5-1 +280 $1.97 $552 225,567 D
Krogulski Kenneth Director 2023-11-03 Other acquisition 10b5-1 +280 $2.06 $577 225,847 D
Krogulski Kenneth Director 2023-11-06 Other acquisition 10b5-1 +280 $2.03 $568 226,127 D
Krogulski Kenneth Director 2023-11-07 Other acquisition 10b5-1 +96 $2.01 $193 226,223 D
Krogulski Kenneth Director 2023-11-08 Other acquisition 10b5-1 +280 $2.00 $560 226,503 D
Krogulski Kenneth Director 2023-11-09 Other acquisition 10b5-1 +280 $1.82 $510 226,783 D
Krogulski Kenneth Director 2023-11-10 Other acquisition 10b5-1 +280 $1.77 $496 227,063 D
Krogulski Kenneth Director 2023-11-13 Other acquisition 10b5-1 +236 $1.75 $413 227,299 D
Krogulski Kenneth Director 2023-11-14 Other acquisition 10b5-1 +280 $1.73 $484 227,579 D
Krogulski Kenneth Director 2023-11-15 Other acquisition 10b5-1 +280 $1.78 $498 227,859 D
Loading xslF345X05/marketforms-63541.xml…